History
# Registration date Revision Id
2 2022-06-10, 1401/03/20 231082
1 2021-12-11, 1400/09/20 208796
Changes made to previous revision
This is the first revision

Protocol summary

Study aim
Determining The effect of date seed powder supplementation on nutritional status, metabolic, oxidative stress and inflammatory parameters in diabetes type 2 patients
Design
This Randomized, three-blind study to determine the effects of date seed powder supplementation on patients with type 2 diabetes will be done. Patients were randomly divided into two groups based on a block randomization procedure of size six by using random allocation software (RAS). Each block involves patients with the same categories of BMI and age.
Settings and conduct
This randomized, three- blind clinical trial will be performed on T2DM patients from the Iran Diabetes Society and Hospitals of Kerman University of Medical Science.
Participants/Inclusion and exclusion criteria
Inclusion criteria included having at least 6 months of history of diabetes, age range 30 to 50 years, BMI between 25 to 30 and no weight changes during the last 3 months, no insulin therapy and use of antihypertensive drugs, propensity to take Date seed powder during the study and exclusion criteria include the use of insulin therapy, specific medications, receiving antioxidant supplements at least three months before the start of the study, a history of weight loss diet during the last 6 months or special diet, the presence of disease or Impairment, alcohol or smoking, pregnancy, lactation, being an athlete, strenuous physical activity and unwillingness to consume palm seed powder and gastrointestinal symptoms during the study.
Intervention groups
The intervention group will receive 5 grams of date seed powder daily for 8 weeks.
Main outcome variables
Glycemic markers (insulin, HbA1c, fasting blood sugar), lipid profile, anti-inflammatory markers (TNF-α, hs-CRP), oxidative stress and antioxidant markers

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20150205020965N10
Registration date: 2021-12-11, 1400/09/20
Registration timing: prospective

Last update: 2021-12-11, 1400/09/20
Update count: 1
Registration date
2021-12-11, 1400/09/20
Registrant information
Name
Parvin Dehghan
Name of organization / entity
Tabriz University Of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 41 3335 7580
Email address
dehghanp@tbzmed.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-01-21, 1400/11/01
Expected recruitment end date
2022-03-21, 1401/01/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of date seed powder supplementation on nutritional status, metabolic, oxidative stress and inflammatory parameters in diabetes type 2 patients
Public title
The effect of date seed powder on diabetes
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Have at least 6 months of diabetes history No weight changes during the last 3 months No insulin therapy Use of blood sugar lowering drugs Tendency to consume palm kernel powder during the study Having a BMI between 25 and 35
Exclusion criteria:
Use of glucocorticoids, laxatives, anti-obesity, multivitamins, nonsteroidal anti-inflammatory drugs (NSAIDS) and antibiotics Take antioxidant supplements at least three months before the start of the study History of weight loss diet in the last 6 months or special diet Having diseases such as intestinal diseases such as inflammation of the intestines, intestinal cancer and digestive problems Having thyroid disorders, heart disease, kidney, liver, lung, infectious and other cancers treated with radiotherapy Alcohol or smoking Pregnancy, breastfeeding, being an athlete or doing strenuous physical activity
Age
From 30 years old to 50 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Participant
  • Investigator
  • Data analyser
Sample size
Target sample size: 40
Randomization (investigator's opinion)
Randomized
Randomization description
At baseline, eligible individuals will be matched for BMI and age according to the classification of these variables. Individuals will be randomly divided into two groups, the intervention group (n=20, receiving date seed powder) control (n=20, receiving Maltodextrin) using RAS software into 2 and 4 blocks, and will be given codes 1 and 2.
Blinding (investigator's opinion)
Triple blinded
Blinding description
After randomization, both groups will be given date seed powder and maltodextrin that encoded in sachets weighing 2.5 g in similar packages (metalized) without the researcher intervention and coded with codes 1 and 2. Until releasing of study results, the patient, the researcher, and the data analyzer will not be aware of the assigned codes. Therefore, the study will be three-blind
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tabriz University of Medical Sciences
Street address
Tabriz University Of Medical Sciences, Nutrition Faculty, Attar Neyshabori Street, Golghash street.
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Approval date
2020-10-16, 1399/07/25
Ethics committee reference number
IR.TBZMED.REC.1400.752

Health conditions studied

1

Description of health condition studied
Type 2 diabetes
ICD-10 code
E11
ICD-10 code description
Type 2 diabetes mellitus

Primary outcomes

1

Description
Lipid profile (TG, TC, HDL-c)
Timepoint
At baseline and three two after baseline
Method of measurement
KIT

2

Description
Total antioxidant capacity
Timepoint
At baseline and three two after baseline
Method of measurement
Kit

3

Description
Malondialdehyde
Timepoint
At baseline and three two after baseline
Method of measurement
kit

4

Description
Tumor Necrosis Factor(TNF)
Timepoint
At baseline and three two after baseline
Method of measurement
kit

5

Description
Highly sensitive C-reactive protein(hs-CRP )
Timepoint
At baseline and three two after baseline
Method of measurement
kit

6

Description
HbA1c
Timepoint
At baseline and three two after baseline
Method of measurement
kit

7

Description
Fasting glucose
Timepoint
At baseline and three two after baseline
Method of measurement
kit

8

Description
Fasting insulin
Timepoint
At baseline and three two after baseline
Method of measurement
kit

Secondary outcomes

1

Description
Body Mass Index (BMI)
Timepoint
At baseline and two months after baseline
Method of measurement
Scale-Meter

2

Description
Amount of received energy
Timepoint
At baseline and two months after baseline
Method of measurement
questionnaire

3

Description
Daily macronutrient intake (carbohydrate, protein, fat)
Timepoint
At baseline and two months after baseline
Method of measurement
questionnaire

Intervention groups

1

Description
Intervention group: date seed powder. This group will consume two sachets of 2.5 g of date seed powder (Flavinea Company, Iran) daily for 2 months in the morning and evening in food such as drinks or yogurt.
Category
Treatment - Other

2

Description
Control group: maltodextrin. The group will consume two sachets of 2.5 g of maltodextrin (Qinhuangdao Lihua Starch co, china) daily for two months in the morning and evening in foods such as beverages or yogurt.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Afzalipour hospital of Kerman
Full name of responsible person
Parvin Dehghan
Street address
Tabriz University Of Medical Sciences, Nutrition Faculty, Attar Neyshabori Street, Golghash street
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 41 3334 0634
Email
dehghan.nut@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Alireza Ostad Rahimi
Street address
Tabriz University Of Medical Sciences, Nutrition Faculty, Attar Neyshabori Street, Golghash street.
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 41 3334 0634
Email
ostadrahimi@tbzmed.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tabriz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Parvin Dehghan
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Tabriz University Of Medical Sciences, Nutrition Faculty, Attar Neyshabori Street, Golghash street.
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 41 3335 7581
Fax
Email
dehghan.nut@gmail.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Parvin Dehghan
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Attar Neyshabori Street, Golghash street, Nutrition Faculty, Tabriz University Of Medical Sciences,
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 41 3335 7580
Fax
Email
dehghanp@tbzmed.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Parvin Dehghan
Position
Associate professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Attar Neyshabori Street, Golghash street, Nutrition Faculty, Tabriz University Of Medical Sciences,
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 41 3335 7580
Fax
Email
dehghanp@tbzmed.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Participant data will be presented in the article without identifiable details
When the data will become available and for how long
2022-2023
To whom data/document is available
Tabriz University of Medical Sciences
Under which criteria data/document could be used
The application must be submitted to Tabriz University of Medical Sciences. It will available if Tabriz University of Medical Sciences is allowed.
From where data/document is obtainable
Tabriz University of Medical Sciences
What processes are involved for a request to access data/document
The application must be submitted to Tabriz University of Medical Sciences. It will available if Tabriz University of Medical Sciences is allowed.
Comments
Loading...